BREAKING
Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 3 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 3 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 3 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 4 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 4 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 3 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 3 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 3 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 4 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 4 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago
ADVERTISEMENT
Market News

ReWalk Robotics (RWLK) stock plunges to a record low

ReWalk Robotics Ltd. (NASDAQ: RWLK) stock plunged to a record low of $1.94 on Friday as the medical devices company has been struggling in achieving the desired results of product sales. Also, investors remained concerned about the future of the company after weak third-quarter results. The company has incurred losses and negative cash flow from […]

$RWLK November 15, 2019 2 min read

ReWalk Robotics Ltd. (NASDAQ: RWLK) stock plunged to a record low of $1.94 on Friday as the medical devices company has been struggling in achieving the desired results of product sales. Also, investors remained concerned about the future of the company after weak third-quarter results.

The company has incurred losses and negative cash flow from operations since inception, and this is likely to continue in the near term. ReWalk Robotics has funded its operations since inception primarily through the sale of certain of its equity securities and convertible notes in private placements, the sale of ordinary shares in public offerings and the incurrence of bank debt.

Image for representation. Courtesy: AbsolutVision on Unsplash

The wearable robots and exoskeletons continue to evolve. The medical sector has adopted exoskeleton technologies for rehabilitation therapy and geriatric support. However, the wearable robots and exoskeletons market is gaining traction in the defense and other industries.

Meanwhile, the demand from the rehabilitation robots market will be driven by the rising aging population and a growing number of stroke rendering people immobile. According to the International Federation of Robotics, the sales of assistance robots for the elderly and disabled communities will total around 37,500 units in 2016-2019 and is likely to increase substantially over the 2019-2024 period.

On Wednesday, Rewalk posted a narrower loss for the third quarter of 2019 helped by lower operating expenses. However, the top line dropped by 25% due to the lesser ReWalk Personal device sold. The results missed the analysts’ expectations. During the quarter, 17 units were placed, including 12 ReWalk Personal units and 5 ReStore units.

ADVERTISEMENT

Read: Aurinia Pharmaceuticals Q3 earnings snapshot

As of September 30, 2019, the company had cash and cash equivalents of $20 million while accumulated deficit amounted to about $165 million. Also, further losses are anticipated in the development of its business.

The company plans to finance operating costs over the next 12 months with existing cash on hand, reducing operating spend, future issuances of equity and debt securities, or through a combination of the foregoing.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT
ADVERTISEMENT